These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 23432070
1. Insulin requirement after a renal transplant in patients with type 2 diabetes: the choice of calcineurin inhibitors. van den Hoogen MW, van der Hoeven AM, Hilbrands LB. Exp Clin Transplant; 2013 Jun; 11(3):234-8. PubMed ID: 23432070 [Abstract] [Full Text] [Related]
2. Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs. Araki M, Flechner SM, Ismail HR, Flechner LM, Zhou L, Derweesh IH, Goldfarb D, Modlin C, Novick AC, Faiman C. Transplantation; 2006 Feb 15; 81(3):335-41. PubMed ID: 16477217 [Abstract] [Full Text] [Related]
3. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation. Batista F, Auyanet I, Torregrosa JV, Oppenheimer F. Transplant Proc; 2012 Nov 15; 44(9):2582-4. PubMed ID: 23146461 [Abstract] [Full Text] [Related]
5. The dynamics of glucose metabolism under calcineurin inhibitors in the first year after renal transplantation in nonobese patients. David-Neto E, Lemos FC, Fadel LM, Agena F, Sato MY, Coccuza C, Pereira LM, de Castro MC, Lando VS, Nahas WC, Ianhez LE. Transplantation; 2007 Jul 15; 84(1):50-5. PubMed ID: 17627237 [Abstract] [Full Text] [Related]
6. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW. Clin Transplant; 1997 Aug 15; 11(4):299-312. PubMed ID: 9267719 [Abstract] [Full Text] [Related]
7. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India. Agarwal SK, Bhowmik D, Mahajan S, Bagchi S. Transpl Infect Dis; 2017 Feb 15; 19(1):. PubMed ID: 27775825 [Abstract] [Full Text] [Related]
9. Effects of calcineurin inhibitors on paraoxonase and arylesterase activity after a kidney transplant. Kahvecioglu S, Ersoy A, Gullulu M, Dirican M. Exp Clin Transplant; 2014 Aug 15; 12(4):334-42. PubMed ID: 24447269 [Abstract] [Full Text] [Related]
13. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor. Sugiyama K, Tsukaguchi M, Toyama A, Satoh H, Saito K, Nakagawa Y, Takahashi K, Tanaka S, Onda K, Hirano T. Exp Clin Transplant; 2014 Jun 15; 12(3):195-9. PubMed ID: 24907718 [Abstract] [Full Text] [Related]
15. Calcineurin inhibitors in renal transplantation: what is the best option? Tanabe K. Drugs; 2003 Jun 15; 63(15):1535-48. PubMed ID: 12887261 [Abstract] [Full Text] [Related]
19. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy. Sato T, Inagaki A, Uchida K, Ueki T, Goto N, Matsuoka S, Katayama A, Haba T, Tominaga Y, Okajima Y, Ohta K, Suga H, Taguchi S, Kakiya S, Itatsu T, Kobayashi T, Nakao A. Transplantation; 2003 Nov 15; 76(9):1320-6. PubMed ID: 14627910 [Abstract] [Full Text] [Related]
20. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. Favi E, Spagnoletti G, Salerno MP, Pedroso JA, Romagnoli J, Citterio F. Clin Transplant; 2013 Nov 15; 27(4):E359-67. PubMed ID: 23710603 [Abstract] [Full Text] [Related] Page: [Next] [New Search]